Photopharmics

Series-B+
photopharmics.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-B+
Last Announced Apr 23, 2025
Investors Undisclosed
Decision Makers 5 Verified

About Photopharmics

Specialists in phototherapy for and other neurodegenerative diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website photopharmics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @photopharmics (162 followers) Created on Jan 2015
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Milestone

    X account created (@photopharmics)

    162 followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Photopharmics.

Funding History

1 Round
Series-B+ · Apr 23, 2025

Founders & Leadership

2

Dan Adams

Science Officer, Co-Founder

Work email & phone locked Unlock →

Kent Savage

CEO, Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts